Stonepine Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$870K	Buy	+92,900	New	+$870K	0.85%	30
2018 Q3	–	Sell	-198,373	Closed	-$1.39M	–	35
2018 Q2	$1.39M	Buy	+198,373	New	+$1.39M	0.85%	20